| Abundance of six tetracycline resistance genes in wastewater lagoons at cattle feedlots with different antibiotic use strategies N Peak, CW Knapp, RK Yang, MM Hanfelt, MS Smith, DS Aga, ... Environmental microbiology 9 (1), 143-151, 2007 | 421 | 2007 |
| Quantification of tetracycline resistance genes in feedlot lagoons by real-time PCR MS Smith, RK Yang, CW Knapp, Y Niu, N Peak, MM Hanfelt, JC Galland, ... Applied and Environmental Microbiology 70 (12), 7372-7377, 2004 | 245 | 2004 |
| Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14. 18-IL2 immunotherapy DC Delgado, JA Hank, J Kolesar, D Lorentzen, J Gan, S Seo, KM Kim, ... Cancer research 70 (23), 9554-9561, 2010 | 193 | 2010 |
| Anti-GD2 strategy in the treatment of neuroblastoma RK Yang, PM Sondel Drugs of the Future 35 (8), 665, 2010 | 146 | 2010 |
| In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments ZS Morris, EI Guy, DM Francis, MM Gressett, LR Werner, LL Carmichael, ... Cancer research 76 (13), 3929-3941, 2016 | 138 | 2016 |
| Correlations between in situ denitrification activity and nir-gene abundances in pristine and impacted prairie streams DW Graham, C Trippett, WK Dodds, JM O’Brien, EBK Banner, IM Head, ... Environmental Pollution 158 (10), 3225-3229, 2010 | 95 | 2010 |
| Intratumoral hu14. 18–IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retention RK Yang, NA Kalogriopoulos, AL Rakhmilevich, EA Ranheim, S Seo, ... The Journal of Immunology 189 (5), 2656-2664, 2012 | 65 | 2012 |
| Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14. 18 antibody increases intratumoral CD8+ T and NK … RK Yang, NA Kalogriopoulos, AL Rakhmilevich, EA Ranheim, S Seo, ... Cancer Immunology, Immunotherapy 62, 1303-1313, 2013 | 52 | 2013 |
| Intratumoral delivery of low doses of anti-CD40 mAb combined with monophosphoryl lipid a induces local and systemic antitumor effects in immunocompetent and T cell-deficient mice TJ Van De Voort, MAR Felder, RK Yang, PM Sondel, AL Rakhmilevich Journal of Immunotherapy 36 (1), 29-40, 2013 | 33 | 2013 |
| The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model BL Soto, JA Hank, TJ Van De Voort, L Subramanian, AS Polans, ... Cancer Immunology, Immunotherapy 60, 731-738, 2011 | 30 | 2011 |
| Pilot trial of the hu14. 18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma MR Albertini, RK Yang, EA Ranheim, JA Hank, CL Zuleger, S Weber, ... Cancer Immunology, Immunotherapy 67, 1647-1658, 2018 | 29 | 2018 |
| T-cell repertoire in combination with T-cell density predicts clinical outcomes in patients with Merkel cell carcinoma M Farah, A Reuben, I Spassova, RK Yang, L Kubat, P Nagarajan, J Ning, ... Journal of Investigative Dermatology 140 (11), 2146-2156. e4, 2020 | 19 | 2020 |
| Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies RK Yang, Y Qing, FZ Jelloul, MJ Routbort, P Wang, K Shaw, J Zhang, ... Oncotarget 11 (6), 600, 2020 | 19 | 2020 |
| Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy–naïve salivary duct carcinomas RK Yang, P Zhao, C Lu, J Luo, R Hu Human pathology 84, 173-182, 2019 | 18 | 2019 |
| Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects AL Rakhmilevich, MJ Baldeshwiler, TJ Van De Voort, MAR Felder, ... Cancer Immunology, Immunotherapy 61, 1683-1697, 2012 | 18 | 2012 |
| Soluble interleukin‐2 receptor α activation in a Children's Oncology Group randomized trial of interleukin‐2 Therapy for Pediatric Acute Myeloid Leukemia BJ Lange, RK Yang, J Gan, JA Hank, EL Sievers, TA Alonzo, RB Gerbing, ... Pediatric blood & cancer 57 (3), 398-405, 2011 | 17 | 2011 |
| Outcome-related signatures identified by whole Transcriptome sequencing of Resectable stage III/IV melanoma evaluated after starting Hu14. 18-IL2 RK Yang, IB Kuznetsov, EA Ranheim, JS Wei, S Sindiri, BE Gryder, ... Clinical Cancer Research 26 (13), 3296-3306, 2020 | 14 | 2020 |
| Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort JA Dottino, Q Zhang, DS Loose, B Fellman, BD Melendez, MS Borthwick, ... American journal of obstetrics and gynecology 224 (3), 278. e1-278. e14, 2021 | 12 | 2021 |
| Clinical testing for mismatch repair in neoplasms using multiple laboratory methods RK Yang, H Chen, S Roy-Chowdhuri, A Rashid, H Alvarez, M Routbort, ... Cancers 14 (19), 4550, 2022 | 10 | 2022 |
| Clinical applications of chromosomal microarray testing in myeloid malignancies A Ronaghy, RK Yang, JD Khoury, R Kanagal-Shamanna Current hematologic malignancy reports 15, 194-202, 2020 | 10 | 2020 |
